---
trial_id: 1694
discovery_date: 2022-07-31 22:37:43.578083
date: 2022-07-31 22:37:43.578083
title: "A 32-week, patient- and rater-blinded, randomized, multi-center, parallel-group study to evaluate disease control and safety in patients with relapsing remitting multiple sclerosis transferred from..."
summary: |
  <p>EudraCT Number: 2011-001442-15<br />Sponsor Protocol Number: CFTY720D2324<br />Sponsor Name: Novartis Pharma Services AG<br />Start Date: 2011-08-26<br />Medical condition: relapsing remitting multiple sclerosis<br />Disease: <br />Version: 14.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/DE">DE</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/GR">GR</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/AT">AT</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/FI">FI</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/HU">HU</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/IT">IT</a> (Prematurely Ended)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-001442-15'
published_date: NaT
trial_source: 
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2011-001442-15<br />Sponsor Protocol Number: CFTY720D2324<br />Sponsor Name: Novartis Pharma Services AG<br />Start Date: 2011-08-26<br />Medical condition: relapsing remitting multiple sclerosis<br />Disease: <br />Version: 14.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/DE">DE</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/GR">GR</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/AT">AT</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/FI">FI</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/HU">HU</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001442-15/IT">IT</a> (Prematurely Ended)</p>